Clinic for Cardiology, Clinical Center of Serbia, 26 Visegradska, 11000, Belgrade, Serbia.
Int J Cardiovasc Imaging. 2013 Aug;29(6):1215-28. doi: 10.1007/s10554-013-0202-1. Epub 2013 Feb 27.
This study evaluated additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). All six scores were calculated in 209 consecutive STEMI patients undergoing pPCI. Primary end-point was the major adverse cardiovascular event (MACE--composite of cardiovascular mortality, non-fatal myocardial infarction and stroke); secondary end point was cardiovascular mortality. Patients were stratified according to the SYNTAX score tertiles (≤12; between 12 and 19.5; >19.5). The median follow-up was 20 months. Rates of MACE and cardiovascular mortality were highest in the upper tertile of the SYNTAX score (p < 0.001 and p = 0.003, respectively). SYNTAX score was independent multivariable predictor of MACE and cardiovascular mortality when added to GRACE, TIMI, ZWOLLE, and PAMI risk scores. However, the SYNTAX score did not improve the Cox regression models of MACE and cardiovascular mortality when added to the CADILLAC score. The SYNTAX score has predictive value for MACE and cardiovascular mortality in patients with STEMI undergoing primary PCI. Furthermore, SYNTAX score improves prognostic performance of well-established GRACE, TIMI, ZWOLLE and PAMI clinical scores, but not the CADILLAC risk score. Therefore, long-term survival in patients after STEMI depends less on detailed angiographical characterization of coronary lesions, but more on clinical characteristics, myocardial function and basic angiographic findings as provided by the CADILLAC score.
本研究评估了 SYNTAX 评分在 ST 段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(pPCI)时相对于 GRACE、TIMI、ZWOLLE、CADILLAC 和 PAMI 风险评分的附加预后价值。在 209 例连续行 pPCI 的 STEMI 患者中计算了所有 6 种评分。主要终点是主要不良心血管事件(MACE——心血管死亡、非致死性心肌梗死和卒中的复合终点);次要终点是心血管死亡率。根据 SYNTAX 评分三分位数(≤12;12~19.5;>19.5)对患者进行分层。中位随访时间为 20 个月。SYNTAX 评分最高三分位组的 MACE 和心血管死亡率最高(p<0.001 和 p=0.003)。在加入 GRACE、TIMI、ZWOLLE 和 PAMI 风险评分后,SYNTAX 评分是 MACE 和心血管死亡率的独立多变量预测因子。然而,当 CADILLAC 评分加入时,SYNTAX 评分并未改善 MACE 和心血管死亡率的 Cox 回归模型。SYNTAX 评分对行直接 PCI 的 STEMI 患者的 MACE 和心血管死亡率具有预测价值。此外,SYNTAX 评分可改善 GRACE、TIMI、ZWOLLE 和 PAMI 等公认临床评分的预后性能,但不能改善 CADILLAC 风险评分。因此,STEMI 患者的长期生存较少取决于冠状动脉病变的详细血管造影特征,而更多地取决于 CADILLAC 评分提供的临床特征、心肌功能和基本血管造影发现。